Ultragenyx Pharmaceutical (RARE): Among Billionaire Stanley Druckenmiller's Top Stock Picks with Huge Upside Potential [Yahoo! Finance]
Ultragenyx Pharmaceutical Inc. (RARE)
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.ultragenyx.com/investor-relations
Company Research
Source: Yahoo! Finance
to take a look at where Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) stands against other Billionaire Stanley Druckenmiller's top stock picks with huge upside potential. Wall Street is overflowing with data. If companies are not releasing their earnings, economic data flows almost daily. This abundance of data can be overwhelming, making it easy to miss important signals. That's why investors monitor billionaires who've made and continue to make their fortunes on Wall Street. The list of these billionaires is long, but a few, such as Warren Buffett and Stanley Druckenmiller, stand out. Druckenmiller is a former Soros protégé who, after 12 years at Soros Fund Management, opted to exit and focus fully on his own hedge fund, Duquesne Capital , in 2000. He later transitioned this outfit into a family office – Duquesne Family Office – in 2010. Over the past eight quarters (up to Q4 2024), the family office has consistently outperformed the S&P 500. The top 20 holdings weighted have ret
Show less
Read more
Impact Snapshot
Event Time:
RARE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RARE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RARE alerts
High impacting Ultragenyx Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
RARE
News
- Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Ultragenyx Pharmaceutical (RARE): Reassessing Valuation After Recent Share Price Rebound [Yahoo! Finance]Yahoo! Finance
- Is Ultragenyx Pharmaceutical (RARE) One of the Best Biotech Stocks to Buy According to Wall Street Analysts? [Yahoo! Finance]Yahoo! Finance
- Ultragenyx (RARE): Assessing Valuation as Revenue Growth and Clinical Progress Fuel Renewed Investor Interest [Yahoo! Finance]Yahoo! Finance
- Ultragenyx to Participate in Investor Conferences in DecemberGlobeNewswire
RARE
Earnings
- 11/4/25 - Miss
RARE
Sec Filings
- 12/11/25 - Form 4
- 12/10/25 - Form 144
- 11/5/25 - Form SCHEDULE
- RARE's page on the SEC website